Home
Subscription
October 2024 issue
September 2024 issue
August 2024 issue
July 2024 issue
June 2024 issue
May 2024 issue
April 2024 issue
April 1, 2024 issue
March 2024 issue
February 2024 issue
January 2024 issue
BACK ISSUES
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
|
2015 Issues
December 2015 Issue
• Feature: How Shall We Live?
• "Support Independents"
• Appreciation
• Indexes for Volume 6, 2011 through Volume 9, 2014
• Index for Volume 10, 2015
November 2015 Issue
• Feature: Medications that Must Be Available without a Prescription from a Pharmacist
• New Drug Review: Brexpiprazole (Rexulti – Otsuka)
October 2015 Issue
• Feature: The FTC should just say NO! to CVS acquiring Target pharmacies and to Walgreens acquiring Rite Aid!
• New Drug Review: Sacubitril/valsartan (Entresto – Novartis)
September 2015 Issue
• Feature: Daraprim – The Ultimate Drug Pricing Outrage?
• New Drug Review: Suvorexant (Belsomra – Merck)
August 2015 Issue
• Feature: CVS Recommendations about the Cholesterol Guidelines are Not Credible When Its Pharmacists Do Not Have Enough Staff and Time to Practice Optimally
• New Therapeutic Agents Marketed in the United States in 2014
July 2015 Issue
• Feature: Time Out!*
• New Drug Review: Edoxaban tosylate monohydrate (Savaysa – Daiichi-Sankyo)
March 2015 Issue
• Feature: PHARMACY'S VISION FOR 2015 [2004-2014 Rest in Peace]
• New Drug Review: Vorapaxar sulfate (Zontivity – Merck)
February 2015 Issue
• Feature: Drug Shortages and High-Priced Generics – Pharmacy Should Establish Our Own Generics Pharmaceutical Company!
• New Drug Review: Olodaterol hydrochloride (Striverdi Respimat – Boehringer Ingelheim)
January 2015 Issue
• Feature: Express Scripts Made the Wrong Formulary Decision that is a Disservice to its Customers
• New Drug Review: Ledipasvir/sofosbuvir (Harvoni – Gilead Sciences)
• New Drug Review: Ombitasvir, paritaprevir, ritonavir, dasabuvir sodium monohydrate (Viekira Pak – AbbVie)
| |
